Incidence

How many new cases of a condition appear in a group of people over a set time, usually given per 100,000 people per year.

Also called: new cases, incidence rate, rate of new diagnoses

Related words prevalence epidemiology

Topics Research About Crohn's disease

Questions people ask

How common is Crohn's disease in the UK?

Estimates vary with how cases are counted. Research funded by Crohn's & Colitis UK found about 1 in 123 people in the UK live with Crohn's or colitis, over half a million people. A large GP-records study found about 276 in every 100,000 people had Crohn's at the end of 2018, with new cases in teenagers almost doubling.

Sources

Can Crohn's affect parts of the body other than the gut?

Yes. European experts have published guidance on problems outside the gut, such as in the joints, skin and eyes. Rarer cases have been reported of Crohn's-type inflammation in the skin, the mouth and lips, and even the lungs. If you notice new symptoms elsewhere in your body, mention them to your IBD team.

Sources

Where to read more

New research shows over 1 in 123 people in UK living with Crohn's or Colitis

Crohn's & Colitis UK Web page Mar 2022 Patients and professionals

Reports a University of Nottingham study, funded by the charity and Coeliac UK, that looked at GP records for 38.3 million people. It found more than half a million people in the UK, about 1 in every 123, live with Crohn's, ulcerative colitis or unclassified IBD, almost twice the previous estimate of 300,000.

Topics About Crohn's disease Research

Jargon explained prevalence incidence

Incidence and prevalence of inflammatory bowel disease in UK primary care: a population-based cohort study

BMJ Open via PubMed Central Study Jul 2020 For professionals

A study of more than 11 million people's GP records from 2000 to 2018 tracking new IBD diagnoses in the UK. It found new cases in adults were stable or falling, but UK rates are among the highest reported anywhere, with a large rise in new diagnoses among teenagers.

Topics About Crohn's disease Research

Jargon explained incidence prevalence cohort study primary care

The incidence and prevalence of inflammatory bowel disease in UK primary care: a retrospective cohort study of the IQVIA Medical Research Database

BMC Gastroenterology Data Mar 2021 For professionals

Another big UK GP-records study, covering 2006 to 2016. It found IBD rose by about a third over that time to roughly 1.4% of patients, higher than earlier estimates. The authors point out that the answer depends heavily on how a 'case' is defined, which may explain why older figures were lower.

Topics About Crohn's disease Research

Jargon explained retrospective cohort study prevalence incidence

Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies

The Lancet Systematic review Dec 2017 For professionals

A review of population studies from around the world. In Western countries the number of new cases is levelling off but more than 0.3% of people now live with IBD. In newly industrialised countries in Asia, Africa and South America, new cases are rising quickly as lifestyles become more Western.

Topics About Crohn's disease Research

Jargon explained systematic review incidence prevalence population-based study

Crohn's disease: How common is it?

NICE Clinical Knowledge Summaries Guide May 2024 For professionals

NICE's GP summary on how common Crohn's is. It says exact figures are not known because studies count cases differently, that new cases are thought to be stable or falling in Europe and the US but rising in newly industrialised countries, and that Crohn's usually starts in the teenage and young adult years, with a median age at diagnosis of about 30. Men and women are affected about equally.

Topics About Crohn's disease Research

Jargon explained incidence prevalence

Upadacitinib Induction and Maintenance Therapy for Crohn's Disease (U-EXCEL, U-EXCEED, U-ENDURE)

New England Journal of Medicine Study May 2023 Patients and professionals

Three trials of upadacitinib (Rinvoq), a daily tablet rather than an injection or drip. It worked better than placebo both for settling active Crohn's over 12 weeks and for keeping it settled over a year. Some side effects, such as liver changes, low white cells and a few cases of bowel perforation, were seen more on the drug, so it needs monitoring.

Topics Medicines Immunosuppressants Research

Jargon explained JAK inhibitor small molecule induction maintenance herpes zoster endoscopic response

Changing patterns in the epidemiology and outcomes of inflammatory bowel disease in the United Kingdom: 2000-2018

Alimentary Pharmacology & Therapeutics Data May 2020 Patients and professionals

Using UK GP records from 2000 to 2017, this study found Crohn's became more common, rising from about 220 to 400 per 100,000 people. It predicted about 1 in 90 people in the UK would have IBD by 2025. Colitis was linked to a higher risk of bowel cancer, and both conditions to a somewhat higher risk of death than people without IBD.

Topics About Crohn's disease Cancer risk and screening Research

Jargon explained epidemiology prevalence hazard ratio all-cause mortality

The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017

The Lancet Gastroenterology & Hepatology via PubMed Central Study Oct 2019 For professionals

Part of the Global Burden of Disease project, estimating about 6.8 million people with IBD worldwide in 2017. Rates were highest in wealthier countries, and the UK had the second highest age-adjusted rate after the USA.

Topics About Crohn's disease Research

Jargon explained prevalence inflammatory bowel disease disability-adjusted life years age-standardised rate

Search everything for "incidence"